{"transactions":[{"id":4386502,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-2 Warrants","published_at":"2017-03-14T16:00:37.000Z","date":"2017-03-08","kind":"purchase","acquired":true,"shares":222223,"ownership":{"direct":false,"nature":"By Vayikra Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 1,000 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Reporting Person has acquired Units consisting of: (a) 1,000 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 222,223 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 222,223 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":222223,"derivative":{"exercise_price":7.75,"exercise_date":"2017-03-08","expiration_date":"2022-03-08","underlying":"Common Stock, par value $0.001 per share","underlying_shares":222223},"source":{"system":"sec-edgar","filing":"0001178913-17-000765","document":"zk1719675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891317000765/zk1719675.xml","form_type":"4"}},{"id":4386501,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-1 Warrants","published_at":"2017-03-14T16:00:37.000Z","date":"2017-03-08","kind":"purchase","acquired":true,"shares":222223,"ownership":{"direct":false,"nature":"By Vayikra Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 1,000 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Reporting Person has acquired Units consisting of: (a) 1,000 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 222,223 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 222,223 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":222223,"derivative":{"exercise_price":4.5,"exercise_date":"2016-11-30","expiration_date":"2022-03-08","underlying":"Common Stock, par value $0.001 per share","underlying_shares":222223},"source":{"system":"sec-edgar","filing":"0001178913-17-000765","document":"zk1719675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891317000765/zk1719675.xml","form_type":"4"}},{"id":4386500,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C 5.5% Convertible Preferred Stock","published_at":"2017-03-14T16:00:37.000Z","date":"2017-03-08","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":false,"nature":"By Vayikra Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Footnote 1 is attached hereto as Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 1,000 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C 5.5% Convertible Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Reporting Person has acquired Units consisting of: (a) 1,000 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 222,223 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 222,223 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1000,"derivative":{"exercise_price":4.5,"exercise_date":"2017-03-08","underlying":"Common Stock, par value $0.001 per share","underlying_shares":222223},"source":{"system":"sec-edgar","filing":"0001178913-17-000765","document":"zk1719675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891317000765/zk1719675.xml","form_type":"4"}},{"id":4535419,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-2 Warrants","published_at":"2016-12-02T13:00:24.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":66667,"ownership":{"direct":false,"nature":"By Vayikra Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 300 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Reporting Person has acquired Units consisting of: (a) 300 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 66,667 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 66,667 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":66667,"derivative":{"exercise_price":7.75,"exercise_date":"2016-11-30","expiration_date":"2021-11-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001178913-16-007072","document":"zk1619271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891316007072/zk1619271.xml","form_type":"4"}},{"id":4535418,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-1 Warrants","published_at":"2016-12-02T13:00:24.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":66667,"ownership":{"direct":false,"nature":"By Vayikra Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Series C-1 Warrants and the Series C-2 Warrants will be subject to adjustment upon the occurrence of those items listed in footnote 1 (with the exception of subsection (b) thereof)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 300 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Reporting Person has acquired Units consisting of: (a) 300 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 66,667 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 66,667 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":66667,"derivative":{"exercise_price":4.5,"exercise_date":"2016-11-30","expiration_date":"2021-11-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001178913-16-007072","document":"zk1619271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891316007072/zk1619271.xml","form_type":"4"}},{"id":4535417,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C 5.5% Convertible Preferred Stock","published_at":"2016-12-02T13:00:24.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":300,"ownership":{"direct":false,"nature":"By Vayikra Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Footnote 1 is attached hereto as Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 300 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (a) one share of Series C 5.5% Convertible Preferred Stock; (b) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Convertible Preferred Stock, at an initial exercise price of $4.50 per share; and (c) one warrant to purchase up to a number of shares of common stock equal to 100% of the number of shares of common stock issuable upon conversion of one share of Series C 5.5% Preferred Stock, at an initial exercise price of $7.75 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C 5.5% Convertible Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Reporting Person has acquired Units consisting of: (a) 300 shares of Series C 5.5% Convertible Preferred Stock, convertible into 66,667 shares of Common Stock; (b) Series C-1 Warrants, exercisable into 66,667 shares of Common Stock; and (c) Series C-2 Warrants, exercisable into 66,667 shares of Common Stock. The conversion of such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants is subject to a beneficial ownership limitation which provides that Vayikra Capital, LLC is not permitted to convert such securities if such conversion would cause the Reporting Person to beneficially own more than 9.99% of the shares of Common Stock outstanding after giving effect to such conversion. The amount of shares of Common Stock of which such Series C 5.5% Convertible Preferred Stock, Series C-1 Warrants and Series C-2 Warrants are convertible into or exercisable for was calculated without giving effect to any ownership limitation of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Vayikra Capital, LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":300,"derivative":{"exercise_price":4.5,"exercise_date":"2016-11-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001178913-16-007072","document":"zk1619271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891316007072/zk1619271.xml","form_type":"4"}},{"id":4547172,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177845,"kind":"person","name":"Darivoff Philip","position":1,"cik":"0001690551","reported_name":"Darivoff Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2016-11-21T12:59:22.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":26666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in 8 equal quarterly installments with the first installment vesting on February 15, 2017 subject to the continued service of the Reporting Person as of each such date."}],"balance_after":26666,"derivative":{"exercise_price":4.5,"expiration_date":"2026-11-15","underlying":"Common Stock, par value $0.001 per share","underlying_shares":26666},"source":{"system":"sec-edgar","filing":"0001178913-16-006995","document":"zk1619231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690551/000117891316006995/zk1619231.xml","form_type":"4"}}]}